Key statistics
As of last trade Sensus Healthcare Inc (SRTS:NAQ) traded at 6.49, -9.68% below its 52-week high of 7.18, set on Aug 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.27 |
---|---|
High | 6.66 |
Low | 6.19 |
Bid | 6.48 |
Offer | 6.49 |
Previous close | 6.32 |
Average volume | 92.22k |
---|---|
Shares outstanding | 16.39m |
Free float | 13.27m |
P/E (TTM) | 15.52 |
Market cap | 103.58m USD |
EPS (TTM) | 0.4072 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 20:39 BST.
More ▼
Announcements
- Sensus Healthcare Sells SRT System to Providence Swedish Hospital
- Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024
- Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024
- Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats
- Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia
- Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
- Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
- Sensus Healthcare to Participate in the 36th Annual Roth Conference
- Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
- Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
More ▼